59th Annual Meeting of the Japanese Society of Neurology

Presentation information

Print

Hot Topics

[HT-02] Nucleic acid therapeutics

Wed. May 23, 2018 1:20 PM - 3:10 PM Room 9 (Royton Sapporo / Regent Hall （2F）)

Chair: Takanori Yokota(Department of Neurology and Neurological Science,Tokyo Medical and Dental University, Japan), Yoshitsugu Aoki(Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan)

Nucleic Acids Therapeutics Society of Japan

[HT-02-1] Engineering selectivity into therapeutic oligonucleotides through chemical design

○Punit P. Seth (Ionis Pharmaceuticals, Inc., Canada)

Dr. Punit P. Seth heads medicinal chemistry at Ionis Pharmaceuticals. Dr. Seth is co-inventor of Ionis’ Gen 2.5 platform which employs high affinity nucleoside modifications to enhance the affinity, stability and potency of ASOs in the liver and in extra-hepatic tissues. He is also the co-inventor of Ionis’ LICA (ligand conjugated antisense oligonucleotides) platform which enhances ASO potency by targeted delivery to cells and tissues of interest. He has extensive experience with using medicinal chemistry strategies to modulate the activity, pharmacokinetics and toxicological properties of oligonucleotide drugs. Dr. Seth is listed as co-author/co-inventor on over 170 peer-reviewed publications and issued patents and patent applications. He has a Ph.D in organic chemistry from The Ohio State University.

Abstract password authentication.
Password is written on a pocket program and name badge.

Password